Prenatal sonographic features of trisomy 13

Journal of Medical Ultrasound

Volumn 15, Issue 1, 2007, Pages 58-66

  Chen, Chih Ping ^a,b   Chien, Shu Chin ^c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Prenatal ultrasound; Trisomy 13

Indexed keywords

ABDOMINAL WALL DEFECT; BRAIN DYSFUNCTION; CONGENITAL MALFORMATION; CYSTITIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FACE MALFORMATION; FETUS; FETUS DEATH; FETUS ECHOGRAPHY; GESTATION PERIOD; HEART DISEASE; HEART SEPTUM DEFECT; HOLOPROSENCEPHALY; HUMAN; IMAGE ANALYSIS; LIMB MALFORMATION; LIVE BIRTH; MECKEL SYNDROME; MENTAL DEFICIENCY; NECK CYST; PALLISTER HALL SYNDROME; PHENOTYPE; REVIEW; SMITH LEMLI OPITZ SYNDROME; SURVIVAL TIME; TACHYCARDIA; TRISOMY 13; UROGENITAL TRACT MALFORMATION;

EID: 34249011459     PISSN: 09296441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6441(08)60024-7     Document Type: Review

References (73)

1. Rasmussen SA, Wong LY, Yang Q, et al. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 2003; 111:777-84.
2. Parker MJ, Budd JL, Draper ES, et al. Trisomy 13 and trisomy 18 in a defined population: epidemiological, genetic and prenatal observations. Prenat Diagn 2003; 23:856-60.
3. Nazer J, Antolini M, Juarez ME, et al. Prevalence of chromosomal aberrations at birth in the Clinical Hospital of Universidad de Chile, 1990-2001. Rev Med Chil 2003;131:651-8.
4. Wyllie JP, Wright MJ, Burn J, et al. Natural history of trisomy 13. Arch Dis Child 1994;71:343-5.
5. Pont SJ, Robbins JM, Bird TM, et al. Congenital malformations among liveborn infants with trisomies 18 and 13. Am J Med Genet A 2006;140:1749-56.
6. Goldstein H, Nielsen KG. Rates and survival of individuals with trisomy 13 and 18. Data from a 10-year period in Denmark. Clin Genet 1988;34:366-72.
7. Taylor AI. Autosomal trisomy syndromes: a detailed study of 27 cases of Edwards' syndrome and 27 cases. of Patau's syndrome. J Med Genet 1968;5:227-52.
8. Conen PE, Erkman B. Frequency and occurrence of chromosomal syndromes. I. D-Trisomy. Am J Hum Genet 1966;18:374-86.
9. Patau K, Smith DW, Therman E, et al. Multiple congenital anomaly caused by an extra autosome. Lancet 1960;1:790-3.
10. Ishikiriyama S, Niikawa N. Origin of extra chromosome in Patau syndrome. Hum Genet 1984;68: 266-8.
11. Snijders RJ, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995;10:356-67.
12. Taslimi MM, Acosta R, Chueh J, et al. Detection of sonographic markers of fetal aneuploidy depends on maternal and fetal characteristics. J Ultrasound Med 2005;24:811-5.
13. Lehman CD, Nyberg DA, Winter TC, et al. Trisomy 13 syndrome: prenatal US findings in a review of 33 cases. Radiology 1995;194:217-22.
14. Picklesimer AH, Moise KJ Jr, Wolfe HM. The impact of gestational age on the sonographic detection of aneuploidy. Am J Obstet Gynecol 2005;193:1243-7.
15. Papageorghiou AT, Avgidou K, Spencer K, et al. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation. Am J Obstet Gynecol 2006;194:397-401.
16. Peebles DM. Holoprosencephaly. Prenat Diagn 1998; 18:477-80.
17. Cohen MM Jr. Holoprosencephaly: clinical, anatomic, and molecular dimensions. Birth Defects Res A Clin Mol Teratol 2006;76:658-73.
18. Warkany J, Passarge E, Smith LB. Congenital malformations in autosomal trisomy syndromes. Am J Dis Child 1966;112:502-17.
19. Kurtz AB, Wapner RJ, Rubin CS, et al. Ultrasound criteria for in utero diagnosis of microcephaly. J Clin Ultrasound 1980; 8:11-6.
20. Pilu G, Reece EA, Romero R, et al. Prenatal diagnosis of craniofacial malformations with ultrasonography. Am J Obstet Gynecol 1986;155:45-50.
21. Filly RA, Chinn DH, Callen PW. Alobar holoprosencephaly: ultrasonographic prenatal diagnosis. Radiology 1984;151:455-9.
22. Papp C, Beke A, Ban Z, et al. Prenatal diagnosis of trisomy 13: analysis of 28 cases. J Ultrasound Med 2006; 25:429-35.
23. Blaas HG, Eik-Nes SH, Vainio T, et al. Alobar holoprosencephaly at 9 weeks gestational age visualized by two- and three-dimensional ultrasound. Ultrasound Obstet Gynecol 2000;15:62-5.
24. Sepulveda W, Dezerega V, Be C. First-trimester sonographic diagnosis of holoprosencephaly: value of the "butterfly" sign. J Ultrasound Med 2004;23:761-5.
25. Souza JP, Siebert JR, Beckwith JB. An anatomic comparison of cebocephaly and ethmocephaly. Teratology 1990;42:347-57.
26. Demyer W, Zeman W, Palmer CG. The face predicts the brain: diagnostic significance of median facial anomalies for holoprosencephaly (arhinencephaly). Pediatrics 1964;34:256-63.
27. Bromley B, Lieberman E, Shipp TD, et al. Fetal nose bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med 2002;21: 1387-94.
28. Cicero S, Curcio P, Papageorghiou A, et al. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001; 358:1665-7.
29. Cicero S, Rembouskos G, Vandecruys H, et al. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan. Ultrasound Obstet Gynecol 2004;23:218-23.
30. Malone FD, Ball RH, Nyberg DA, et al. First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol 2004;104:1222-8.
31. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191:45-67.
32. Cicero S, Spencer K, Avgidou K, et al. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening. Prenat Diagn 2005;25:977-83.
33. Wladimiroff JW, Bhaggoe WR, Kristelijn M, et al. Sonographically determined anomalies and outcome in 170 chromosomally abnormal fetuses. Prenat Diagn 1995;15:431-8.
34. Castilla EE, Lugarinho R, da Graca Dutra M, et al. Associated anomalies in individuals with polydactyly. Am J Med Genet 1998;80:459-65.
35. Brantberg A, Blaas HG, Haugen SE, et al. Characteristics and outcome of 90 cases of fetal omphalocele. Ultrasound Obstet Gynecol 2005;26:527-37.
36. Snijders RJ, Sebire NJ, Souka A, et al. Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation. Ultrasound Obstet Gynecol 1995;6:250-5.
37. Souka AP, Snijders RJ, Novakov A, et al. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998;11: 391-400.
38. Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal medicine foundation first trimester screening group. Lancet 1998;352:343-6.
39. Kagan KO, Avgidou K, Molina FS, et al. Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol 2006; 107:6-10.
40. Spencer K, Ong C, Skentou H, et al. Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000;20:411-6.
41. Levy DW, Mintz MC. The left ventricular echogenic focus: a normal finding. AJR Am J Roentgenol 1988; 150:85-6.
42. Schechter AG, Fakhry J, Shapiro LR, et al. In utero thickening of the chordae tendinae. A cause of intracardiac echogenic foci. J Ultrasound Med 1987;6:691-5.
43. Shipp TD, Bromley B, Lieberman E, et al. The frequency of the detection of fetal echogenic intracardiac foci with respect to maternal race. Ultrasound Obstet Gynecol 2000;15:460-2.
44. Roberts DJ, Genest D. Cardiac histologic pathology characteristic of trisomies 13 and 21. Hum Pathol 1992; 23:1130-40.
45. Nyberg DA, Souter VL. Sonographic markers of fetal trisomies: second trimester. J Ultrasound Med 2001; 20:655-74.
46. Liao AW, Snijders R, Geerts L, et al. Fetal heart rate in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol 2000;16:610-3.
47. Hyett JA, Noble PL, Snijders RJ, et al. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1996;7:239-44.
48. Rempen A. Diagnosis of viability in early pregnancy with vaginal sonography. J Ultrasound Med 1990;9:711-6.
49. Wisser J, Dirschedl P. Embryonic heart rate in dated human embryos. Early Hum Dev 1994;37:107-15.
50. Sebire NJ, Von Kaisenberg C, Rubio C, et al. Fetal megacystis at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1996;8:387-90.
51. Liao AW, Sebire NJ, Geerts L, et al. Megacystis at 10-14 weeks of gestation: chromosomal defects and outcome according to bladder length. Ultrasound Obstet Gynecol 2003;21:338-41.
52. Meckel JF. Beschreibung zweier, durch sehr aehnliche. Bildungsabweichungen entsellter Geschwister. Dtsch Arch Physiol 1822;7:99-172. [In German]
53. Gruber GB. Beitraege zur Frage "gekoppelter" missbildungen. (Akrocephalo-Syndactylie und Dysencephalia splanchnocystica) Beitr Path Anat 1934;93: 459-76. [In German]
54. Paavola P, Salonen R, Weissenbach J, et al. The locus for Meckel syndrome with multiple congenital anomalies maps to chromosome 17q21-q24. Nat Genet 1995;11:213-5.
55. Roume J, Genin E, Cormier-Daire V, et al. A gene for Meckel syndrome maps to chromosome 11q13. Am J Hum Genet 1998;63:1095-101.
56. Smith UM, Consugar M, Tee LJ, et al. The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat. Nat Genet 2006; 38:191-6.
57. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-1983. A 27-year-old woman with an abnormal fetus demonstrated by ultrasound examination. N Engl J Med 1983; 308:642-8.
58. Fraser FC, Lytwyn A. Spectrum of anomalies in the Meckel syndrome, or: "Maybe there is a malformation syndrome with at least one constant anomaly." Am J Med Genet 1981;9:67-73.
59. Cohen MM Jr, Gorlin RJ. Pseudo-trisomy 13 syndrome. Am J Med Genet 1991;39:332-7.
60. Ramos-Arroyo MA, de Miguel C, Valiente A, et al. Further delineation of pseudotrisomy 13 syndrome: a case without polydactyly. Am J Med Genet 1994;50:177-9.
61. Lurie IW, Wulfsberg EA. "Holoprosencephaly-polydactyly" (pseudotrisomy 13) syndrome: expansion of the phenotypic spectrum. Am J Med Genet 1993;47:405-9.
62. Schulz S, Gerloff C, Kalinski T, et al. Pseudotrisomy 13: clinical findings and genetic implications. Fetal Diagn Ther 2005;20:501-3.
63. Bachman H, Clark RD, Salahi W. Holoprosencephaly and polydactyly: a possible expression of the hydrolethalus syndrome. J Med Genet 1990;27:50-2.
64. Amor DJ, Woods CG. Pseudotrisomy 13 syndrome in siblings. Clin Dysmorphol 2000;9:115-8.
65. Seller MJ, Chitty LS, Dunbar H. Pseudotrisomy 13 and autosomal recessive holoprosencephaly. J Med Genet 1993;30:970-1.
66. Tint GS, Irons M, Elias ER, et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 1994;330:107-13.
67. Fitzky BU, Witsch-Baumgartner M, Erdel M, et al. Mutations in the delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci USA 1998;95:8181-6.
68. McGaughran J, Donnai D, Clayton P, et al. Diagnosis of Smith-Lemli-Opitz syndrome. N Engl J Med 1994; 330:1685-6.
69. Jezela-Stanek A, Malunowicz EM, Ciara E, et al. Maternal urinary steroid profiles in prenatal diagnosis of Smith-Lemli-Opitz syndrome: first patient series comparing biochemical and molecular studies. Clin Genet 2006;69:77-85.
70. Johnston JJ, Olivos-Glander I, Killoran C, et al. Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations. Am J Hum Genet 2005;76: 609-22.
71. Iafolla K, Fratkin JD, Spiegel PK, et al. Case report and delineation of the congenital hypothalamic hamartoblastoma syndrome (Pallister-Hall syndrome). Am J Med Genet 1989;33:489-99.
72. Salonen R, Herva R, Norio R. The hydrolethalus syndrome: delineation of a "new", lethal malformation syndrome based on 28 patients. Clin Genet 1981;19: 321-30.
73. Mee L, Honkala H, Kopra O, et al. Hydrolethalus syndrome is caused by a missense mutation in a novel gene HYLS1. Hum Mol Genet 2005;14:1475-88.